Comparative values of catecholamines and metabolites for the diagnosis of neuroblastoma

European Journal of Pediatrics

Volumn 162, Issue 6, 2003, Pages 397-402

  Monsaingeon, Maud ^a   Perel, Yves ^b   Simonnet, Guy ^a   Corcuff, Jean Benoît ^a  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b HÔPITAL PELLEGRIN   (France)

Author keywords

Neuroblastoma; Urinary catecholamines

Indexed keywords

CATECHOLAMINE DERIVATIVE; CREATININE; HOMOVANILLIC ACID; HORMONE; NORMETADRENALIN; VANILMANDELIC ACID;

ADOLESCENT; ADRENAL GLAND; ARTICLE; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; ELECTROCHEMICAL DETECTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE RELEASE; HUMAN; INFANT; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; METABOLITE; NEUROBLASTOMA; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; URINALYSIS;

EID: 0038281285     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-003-1175-1     Document Type: Article

References (19)

1. Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP, De Bernardi B, Evans AE, Favrot M, Hedborg F (1993) Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11: 1466-1477
2. Candito M, Thyss A, Albertini M, Deville A, Politano S, Mariani R, Chambon P (1992) Methylated catecholamine metabolites for diagnosis of neuroblastoma. Med Pediatr Oncol 20: 215-220
3. Cotterill SJ, Pearson AD, Pritchard J, Foot AB, Roald B, Kohler JA, Imeson J (2000) Clinical prognostic factors in 1277 patients with neuroblastoma: results of The European Neuroblastoma Study Group 'Survey' 1982-1992. Eur J Cancer 36: 901-908
4. Esteve J, Parker L, Roy P, Herrmann F, Duffy S, Frappaz D, Lasset C, Hill C, Sancho-Garnier H, Michaelis J, Philip T (1995) Is neuroblastoma screening evaluation needed and feasible? Br J Cancer 71: 1125-1131
5. Gardet V, Gatta B, Simonnet G, Tabarin A, Chene G, Ducassou D, Corcuff JB (2001) Lessons from an unpleasant surprise: a biochemical strategy for the diagnosis of pheochromocytoma. J Hypertens 19: 1029-1035
6. Graham-Pole J, Salmi T, Anton AH, Abramowsky C, Gross S (1983) Tumor and urine catecholamines (CATs) in neurogenic tumors. Correlations with other prognostic factors and survival. Cancer 51: 834-839
7. Helson L, Johnson GA, Smith R (1980) DOPA metabolism in neuroblastoma. Med Pediatr Oncol 8: 317-322
8. Itoh T, Omori K (1973) Biosynthesis and storage of catecholamines in pheochromocytoma and neuroblastoma cells. J Lab Clin Med 81: 889-896
9. LaBrosse EH, Com-Nougue C, Zucker JM, Comoy E, Bohuon C, Lemerle J, Schweisguth O (1980) Urinary excretion of 3-methoxy-4-hydroxymandelic acid and 3-methoxy-4-hydroxyphenylacetic acid by 288 patients with neuroblastoma and related neural crest tumors. Cancer Res 40: 1995-2001
10. Laug WE, Siegel SE, Shaw KN, Landing B, Baptista J, Gutenstein M (1978) Initial urinary catecholamine metabolite concentrations and prognosis in neuroblastoma. Pediatrics 62: 77-83
11. Marchese N, Canini S, Fabi L, Famularo L (1997) Paediatric reference values for urinary catecholamine metabolites evaluated by high performance liquid chromatography and electrochemical detection. Eur J Clin Chem Clin Biochem 35: 533-537
12. Nishi M, Miyake H, Takeda T, Hanai J, Kikuchi Y, Hirama T (1998) Mass screening for neuroblastoma targeting children aged 14 months in Sapporo City: a preliminary report. Cancer 82: 1973-1977
13. O'Meara A, Tormey W, FitzGerald RJ, Fitzgibbon M, Kenny D (1994) Interpretation of random urinary catecholamines and their metabolites in neuroblastoma. Acta Paediatr 83: 88-92
14. Pritchard J, Barnes J, Germond S, Hartman O, de Kraker J, Lewis I, Lockwood L, Wallendszus K (1989) Stage and urinary catecholamine metabolite excretion in neuroblastoma. European Neuroblastoma Study Group. Lancet 2: 514-515
15. Shimada H, Chatten J, Newton WA Jr, Sachs N, Hamoudi AB, Chiba T, Marsden HB, Misugi K (1984) Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 73: 405-416
16. Tuchman M, Ramnaraine ML, Woods WG, Krivit W (1987) Three years of experience with random urinary homovanillic and vanillylmandelic acid levels in the diagnosis of neuroblastoma. Pediatrics 79: 203-205
17. Tuchman M, Lemieux B, Auray-Blais C, Robison LL, Giguere R, McCann MT, Woods WG (1990) Screening for neuroblastoma at 3 weeks of age: methods and preliminary results from the Quebec Neuroblastoma Screening Project. Pediatrics 86: 765-773
18. Zar JH (1984) Biostatistical analysis. Prentice-Hall, Englewood Cliffs
19. Zweig MH, Campbell G (1993) Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39: 561-577